Who owns ADIAL PHARMACEUTICALS INC?
- Ticker: ADIL
- CUSIP Number: 00688a304
Tip: Access positions for across all investors
Analyze quarterly positions in Adial Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adial Pharmaceuticals stock
Who bought or sold ADIAL PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Jane Street | 32k | $82k | 100% | Jun 2026 |
|
| Citadel Advisors | 30k | $76k | 100% | Jun 2026 |
|
| Intl Fcstone | 20k | $36k | 100% | Jun 2026 |
|
| UBS Group | 19k | $49k | 3433% | Jun 2026 |
|
| Geode Capital Management | 12k | $32k | -49% | Jun 2026 |
|
| China Universal Asset Management | 8.0k | $21k | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 5.9k | $15k | 0% | Jun 2026 |
|
| Vanguard Capital Management | 5.8k | $15k | 1515% | Jun 2026 |
|
| Manchester Capital Management | 1.9k | $4.9k | 0% | Jun 2026 |
|
| Tower Research Capital | 1.4k | $3.6k | 5% | Jun 2026 |
|
| BlackRock | 304.00 | $777.996800 | -73% | Jun 2026 |
|
| Raffa Wealth Management | 83.00 | $211.998600 | 0% | Jun 2026 |
|
| Morgan Stanley | 50.00 | $90.000000 | 100% | Mar 2026 |
|
| SBI Securities | 47.00 | $120.000400 | 0% | Jun 2026 |
|
| Wells Fargo & Company | 6.00 | $15.000000 | 0% | Jun 2026 |
|
| Harbour Investments | 3.00 | $8.000100 | 0% | Jun 2026 |
|
| Abound Wealth Management | 1.00 | $3.000000 | 0% | Jun 2026 |
|
Who sold out of Adial Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Caitong International Asset Management | Mar 2026 | 15.00 | $27.000000 |
| Northwestern Mutual Wealth Management Company | Mar 2026 | 4.00 | $7.000000 |